• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过桑格测序法确认下一代测序基因panel检测中的变异体

Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.

作者信息

Baudhuin Linnea M, Lagerstedt Susan A, Klee Eric W, Fadra Numrah, Oglesbee Devin, Ferber Matthew J

机构信息

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

出版信息

J Mol Diagn. 2015 Jul;17(4):456-61. doi: 10.1016/j.jmoldx.2015.03.004. Epub 2015 May 8.

DOI:10.1016/j.jmoldx.2015.03.004
PMID:25960255
Abstract

Current clinical laboratory practice guidelines for next-generation sequencing (NGS) do not provide definitive guidance on confirming NGS variants. Sanger confirmation of NGS results can be inefficient, redundant, and expensive. We evaluated the accuracy of NGS-detected single-nucleotide variants (SNVs) and insertion/deletion variants (indels) and the necessity of NGS variant confirmation using four NGS target-capture gene panels covering 117 genes, 568 Kbp, and 77 patient DNA samples. Unique NGS-detected variants (1080 SNVs and 124 indels) underwent Sanger confirmation and/or were compared to data from the 1000 Genomes Project (1000G). Recurrent variants in unrelated samples resulted in 919 comparisons between NGS and Sanger, with 100% concordance. In a second comparison, 762 unique NGS results (736 SNVs, 26 indels) from seven 1000G samples were found to have 97.1% concordance with 1000G phase 1 data. Sanger sequencing and 1000G phase 3 data confirmed the accuracy of the NGS results for all 1000G phase 1 discrepancies. In all samples, the depth of coverage exceeded 100× in >99.7% of bases in the target regions. In conclusion, confirmatory analysis by Sanger sequencing of SNVs detected via capture-based NGS testing that meets appropriate quality thresholds is unnecessarily redundant. In contrast, Sanger sequencing for indels may be required for defining the correct genomic location, and Sanger may be used for quality-assurance purposes.

摘要

当前关于下一代测序(NGS)的临床实验室操作指南并未就确认NGS变异提供明确指导。对NGS结果进行桑格测序确认可能效率低下、多余且昂贵。我们使用覆盖117个基因、568千碱基对的4个NGS靶向捕获基因panel以及77份患者DNA样本,评估了NGS检测到的单核苷酸变异(SNV)和插入/缺失变异(indel)的准确性以及NGS变异确认的必要性。通过NGS检测到的独特变异(1080个SNV和124个indel)进行了桑格测序确认和/或与千人基因组计划(1000G)的数据进行了比较。无关样本中的重复变异导致NGS与桑格测序之间进行了919次比较,一致性为100%。在第二次比较中,发现来自7个1000G样本的762个独特NGS结果(736个SNV、26个indel)与1000G一期数据的一致性为97.1%。桑格测序和1000G三期数据证实了所有1000G一期差异中NGS结果的准确性。在所有样本中,目标区域中>99.7%的碱基覆盖深度超过100倍。总之,对通过基于捕获的NGS检测且达到适当质量阈值所检测到的SNV进行桑格测序确认分析是不必要的多余操作。相比之下,可能需要对indel进行桑格测序以确定正确的基因组位置,并且桑格测序可用于质量保证目的。

相似文献

1
Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.通过桑格测序法确认下一代测序基因panel检测中的变异体
J Mol Diagn. 2015 Jul;17(4):456-61. doi: 10.1016/j.jmoldx.2015.03.004. Epub 2015 May 8.
2
Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants.下一代测序变异的桑格验证的系统评价
Clin Chem. 2016 Apr;62(4):647-54. doi: 10.1373/clinchem.2015.249623. Epub 2016 Feb 4.
3
Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.在新一代测序 panel 检测中,需要进行桑格验证以实现最佳的灵敏度和特异性。
J Mol Diagn. 2016 Nov;18(6):923-932. doi: 10.1016/j.jmoldx.2016.07.006. Epub 2016 Oct 6.
4
Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.一种包含BRCA1和BRCA2基因的用于评估遗传性癌症风险的25基因二代测序检测板的开发与分析验证。
BMC Cancer. 2015 Apr 2;15:215. doi: 10.1186/s12885-015-1224-y.
5
Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory.评估临床分子诊断实验室中对全外显子测序结果进行验证性检测的必要性。
Genet Med. 2014 Jul;16(7):510-5. doi: 10.1038/gim.2013.183. Epub 2014 Jan 9.
6
Confirmation of Insertion, Deletion, and Deletion-Insertion Variants Detected by Next-Generation Sequencing.通过下一代测序检测到的插入、缺失和缺失-插入变异的确认
Clin Chem. 2023 Oct 3;69(10):1155-1162. doi: 10.1093/clinchem/hvad110.
7
A machine learning model to determine the accuracy of variant calls in capture-based next generation sequencing.基于捕获的下一代测序中变异调用准确性的机器学习模型。
BMC Genomics. 2018 Apr 17;19(1):263. doi: 10.1186/s12864-018-4659-0.
8
A comprehensive assessment of Next-Generation Sequencing variants validation using a secondary technology.利用辅助技术对下一代测序变异进行全面评估。
Mol Genet Genomic Med. 2019 Jul;7(7):e00748. doi: 10.1002/mgg3.748. Epub 2019 Jun 4.
9
Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.在靶向基因panel分析中,临床下一代测序流程优于使用桑格测序和多重连接依赖探针扩增的联合方法。
J Mol Diagn. 2016 Sep;18(5):657-667. doi: 10.1016/j.jmoldx.2016.04.002. Epub 2016 Jul 2.
10
Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.下一代测序技术在遗传性听力损失分子诊断中的性能评估。
Otolaryngol Head Neck Surg. 2013 Jun;148(6):1007-16. doi: 10.1177/0194599813482294. Epub 2013 Mar 22.

引用本文的文献

1
Determination of high-confidence germline genetic variants in next-generation sequencing through machine learning models: an approach to reduce the burden of orthogonal confirmation.通过机器学习模型确定下一代测序中的高可信度种系遗传变异:一种减轻正交确认负担的方法。
BMC Genomics. 2025 Aug 6;26(1):728. doi: 10.1186/s12864-025-11889-z.
2
Sanger validation of WGS variants.全基因组测序(WGS)变异的桑格验证
Sci Rep. 2025 Jan 29;15(1):3621. doi: 10.1038/s41598-025-87814-x.
3
Genetic characterization of intramuscular myxomas.肌内黏液瘤的遗传学特征
Pathol Oncol Res. 2024 Jan 22;30:1611553. doi: 10.3389/pore.2024.1611553. eCollection 2024.
4
Improving the filtering of false positive single nucleotide variations by combining genomic features with quality metrics.通过将基因组特征与质量指标相结合,提高假阳性单核苷酸变异的过滤效果。
Bioinformatics. 2023 Dec 1;39(12). doi: 10.1093/bioinformatics/btad694.
5
Mastering DNA chromatogram analysis in Sanger sequencing for reliable clinical analysis.掌握桑格测序中的DNA色谱图分析以进行可靠的临床分析。
J Genet Eng Biotechnol. 2023 Nov 13;21(1):115. doi: 10.1186/s43141-023-00587-6.
6
A feasible molecular diagnostic strategy for rare genetic disorders within resource-constrained environments.一种适用于资源受限环境中罕见遗传疾病的可行分子诊断策略。
J Community Genet. 2024 Feb;15(1):39-48. doi: 10.1007/s12687-023-00674-8. Epub 2023 Oct 10.
7
Considerations on the use of carrier screening testing in human reproduction: comparison between recommendations from the Italian Society of Human Genetics and other international societies.关于在人类生殖中使用携带者筛查检测的思考:意大利人类遗传学会与其他国际学会的建议比较。
J Assist Reprod Genet. 2022 Nov;39(11):2581-2593. doi: 10.1007/s10815-022-02653-3. Epub 2022 Nov 12.
8
From the patient to the population: Use of genomics for population screening.从患者到人群:基因组学在人群筛查中的应用。
Front Genet. 2022 Oct 24;13:893832. doi: 10.3389/fgene.2022.893832. eCollection 2022.
9
Clustering of Genetic Anomalies of Cilia Outer Dynein Arm and Central Apparatus in Patients with Transposition of the Great Arteries.大动脉转位患者的纤毛外动力臂和中心体遗传异常聚类。
Genes (Basel). 2022 Sep 16;13(9):1662. doi: 10.3390/genes13091662.
10
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer.TERT 启动子重复序列的保守特征揭示了一种激活机制,该机制模拟了癌症中的热点突变。
Nat Commun. 2022 Sep 16;13(1):5430. doi: 10.1038/s41467-022-33099-x.